| Bioactivity | Depramine (GP 31406) is a tricyclic antidepressant with pharmacologically activity. Depramine inhibits acetylcholinesterase，Mg2+-ATPase，and Na+/K+ ATPase activity[1][2]. | ||||||||||||
| Target | Acetylcholinesterase (AChE), Mg2+-ATPase, Na+/K+ ATPase | ||||||||||||
| Name | Depramine | ||||||||||||
| CAS | 303-54-8 | ||||||||||||
| Formula | C19H22N2 | ||||||||||||
| Molar Mass | 278.39 | ||||||||||||
| Appearance | Oil | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Caratsch CG, et al. Tricyclic antidepressants: action on synaptosomal acetylcholinesterase and ATPase in the brain of guinea pigs and subcellular distribution. Neuropharmacology. 1973 Jun;12(6):563-75. |